Rabitec

Authorised

This medicine is authorised for use in the European Union

rabies vaccine (live, oral) for foxes and raccoon dogs

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Rabitec : EPAR - Medicine overview

Reference Number: EMA/654025/2017

Product information

Rabitec : EPAR - Product Information

Rabitec : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Rabitec
• Active substance:
  attenuated live rabies vaccine virus, strain SPBN GASGAS
• International non-proprietary name (INN) or common name:
  rabies vaccine (live, oral) for foxes and raccoon dogs

Pharmacotherapeutic group

• Immunologicals for canidae
• Live viral vaccines

Authorisation details

• EMA product number:
  EMEA/V/C/004387

Assessment history

Changes since initial authorisation of medicine

Rabitec : EPAR - Procedural steps taken and scientific information after authorisation

CVMP post-authorisation summary of positive opinion for Rabitec (VRA-0011)

Adopted Reference Number: EMA/CVMP/95671/2024

Rabitec-V-C-004387-II-0002 : EPAR - Assessment report - Variation

Adopted Reference Number: EMA/56879/2020

CVMP post-authorisation summary of positive opinion for Rabitec (II-0002)

Adopted Reference Number: EMA/CVMP/691934/2019

Initial marketing authorisation documents

Rabitec : EPAR - Public assessment report

Adopted Reference Number: EMA/666973/2017

CVMP summary of positive opinion for Rabitec

Adopted Reference Number: EMA/CVMP/601163/2017